Glucocorticoid induced G-CSF in lung inflammation
糖皮质激素诱导 G-CSF 治疗肺部炎症
基本信息
- 批准号:9336499
- 负责人:
- 金额:$ 39.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcute Lung InjuryAdult Respiratory Distress SyndromeAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryApoptosisAsthmaCSF3 geneCellsColony-Stimulating Factor ReceptorsCurcuminDNA Polymerase IIDNA SequenceDataDimerizationDiseaseDisease ResistanceEpithelial CellsEventGenetic TranscriptionGlucocorticoid ReceptorGlucocorticoidsGoalsGranulocyte-Macrophage Colony-Stimulating FactorIL8 geneIn Situ HybridizationIn VitroInflammationInflammatoryInterleukin-1 betaInterleukin-17Knockout MiceLeukocytesLungLung InflammationMediatingMediator of activation proteinModelingMolecularMusNeutrophiliaOdds RatioOsteocytesPartner in relationshipPatientsPharmaceutical PreparationsPilot ProjectsProductionRecruitment ActivityRegimenResistanceRespiratory physiologyResponse ElementsRoleSignal TransductionSiteSourceSteroid ResistanceStimulusStructure of parenchyma of lungSystemT-LymphocyteTNF geneTNFRSF5 geneTechniquesTestingairway inflammationasthmaticcell typechemokinecytokinehistone modificationimprovedin vitro activityin vivoinhibitor/antagonistlung injurymacrophagemouse modelneutralizing antibodyneutrophilnovel therapeutic interventionp65parthenolidepromoterresponsetrafficking
项目摘要
Project Summary: Glucocorticoids are indispensable in the treatment of inflammation although they are not
effective in treating neutrophilic lung inflammation in severe asthma and acute respiratory distress syndrome.
Our long-term goal is to develop new glucocorticoid regimens with improved efficacy/risk ratios. The goal of
this proposal is to determine whether eliminating G-CSF signaling will allow glucocorticoids to promote
neutrophil apoptosis and ameliorate lung inflammation. We have recently discovered that glucocorticoids
significantly elevate G-CSF, a neutrophil promoting cytokine. G-CSF in recent years has been recognized as a
cause of steroid-resistant lung inflammatory disorders. We hypothesize that glucocorticoids protect neutrophil
from apoptosis and enhance neutrophil function via stimulation of G-CSF. G-CSF induction is initiated by GR
and NF-B p50 interaction on the G-CSF promoter. Glucocorticoid-induction of G-CSF production in lung
resident cells sustains lung inflammation. Blocking G-CSF signaling will increase the efficacy of glucocorticoids
in circumventing neutrophil-driven lung inflammation. To test our hypotheses, we will examine systems in vitro
and in vivo. Studies in Aim 1 will test the hypothesis that GR and p50 interactions mediate G-CSF expression
in various cell types in lungs. Studies in Aim 2 will determine the role of glucocorticoid-induced G-CSF in
neutrophil survival, functions, trafficking, and neutrophilic lung inflammation in two murine models. We will use
three approaches to block G-CSF induction: using G-CSFR null mice, anti-G-CSF neutralizing antibodies, and
two natural NF-B inhibitors that we have identified to be able to inhibit G-CSF-induction: curcumin and
parthenolide. Our preliminary data indicate that both the glucocorticoid receptor (GR) and NF-B were required
for G-CSF induction and p50, but not p65, was recruited to the same region of G-CSF promoter as GR.
Multiple lung resident cells and infiltrating leukocytes produced G-CSF upon glucocorticoid stimulation.
Blocking G-CSF signaling using neutralizing antibodies abolished glucocorticoid and IL-1β protection of
neutrophils from undergoing apoptosis. Curcumin in combination with glucocorticoids reduced lung G-CSF and
neutrophil numbers in an LPS lung injury model. The proposed studies will improve our understanding of the
role of glucocorticoid-induced G-CSF in neutrophil-dominant glucocorticoid-resistant diseases. Inhibiting G-
CSF signaling is anticipated to increase the ability of glucocorticoids to suppress the airway-damaging
activities of neutrophils and ameliorate lung inflammation.
项目摘要:糖皮质激素在炎症的治疗中是必不可少的
有效治疗严重哮喘和急性呼吸窘迫综合征中嗜中性肺部感染。
我们的长期目标是开发具有提高效率/风险比率的新糖皮质激素方案。目标
该建议是确定消除G-CSF信号是否会允许糖皮质激素促进
中性粒细胞凋亡和改善肺部感染。我们最近发现糖皮质激素
显着升高G-CSF,这是一种促进细胞因子的中性粒细胞。近年来G-CSF被认为是
耐肺炎症性疾病的原因。我们假设糖皮质激素保护中性粒细胞
通过刺激G-CSF来凋亡并增强中性粒细胞功能。 G-CSF诱导是由GR引发的
G-CSF启动子上的NF-BP50相互作用。肺中G-CSF产生的糖皮质激素诱导
居民细胞维持肺部注射。阻断G-CSF信号会提高糖皮质激素的效率
在规避嗜中性粒细胞驱动的肺注射中。为了检验我们的假设,我们将在体外检查系统
和体内。 AIM 1中的研究将检验GR和P50相互作用介导G-CSF表达的假设
在肺中的各种细胞类型中。 AIM 2中的研究将确定糖皮质激素诱导的G-CSF在
两种鼠模型中的中性粒细胞存活,功能,运输和中性粒细胞肺注射。我们将使用
阻止G-CSF诱导的三种方法:使用G-CSFR无效小鼠,抗G-CSF中和抗体和
我们已经确定能够抑制G-CSF诱导的两个天然NF-B抑制剂:姜黄素和
parthenolide。我们的初步数据表明糖皮质激素受体(GR)和NF-B都需要
对于G-CSF诱导和P50而非P65,招募到G-CSF启动子的同一区域。
多个肺居民细胞和浸润白细胞在糖皮质激素刺激后产生G-CSF。
使用中和抗体阻止G-CSF信号传导,以取消糖皮质激素和IL-1β保护
嗜中性粒细胞因凋亡而产生。姜黄素与糖皮质激素结合减少了肺G-CSF,并且
LPS肺损伤模型中的中性粒细胞数。拟议的研究将提高我们对
糖皮质激素诱导的G-CSF在中性粒细胞糖皮质激素耐药性疾病中的作用。抑制g-
预计CSF信号传导会增加糖皮质激素抑制气道破坏的能力
中性粒细胞的活性和改善肺部感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NICK LU其他文献
NICK LU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NICK LU', 18)}}的其他基金
Glucocorticoids and glucocorticoid receptor translational isoforms
糖皮质激素和糖皮质激素受体翻译亚型
- 批准号:
8773073 - 财政年份:2014
- 资助金额:
$ 39.13万 - 项目类别:
Glucocorticoids and glucocorticoid receptor translational isoforms
糖皮质激素和糖皮质激素受体翻译亚型
- 批准号:
8890110 - 财政年份:2014
- 资助金额:
$ 39.13万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
8240049 - 财政年份:2009
- 资助金额:
$ 39.13万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
7838659 - 财政年份:2009
- 资助金额:
$ 39.13万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
7786958 - 财政年份:2009
- 资助金额:
$ 39.13万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
8477836 - 财政年份:2009
- 资助金额:
$ 39.13万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
7663499 - 财政年份:2009
- 资助金额:
$ 39.13万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
8448648 - 财政年份:2009
- 资助金额:
$ 39.13万 - 项目类别:
Glucocorticoid receptor translational isoforms in asthma
哮喘中的糖皮质激素受体翻译亚型
- 批准号:
8051828 - 财政年份:2009
- 资助金额:
$ 39.13万 - 项目类别:
Environment and Obesity: preventing stress hormone-induced obesity with genistein
环境与肥胖:用金雀异黄素预防应激激素引起的肥胖
- 批准号:
7090949 - 财政年份:2007
- 资助金额:
$ 39.13万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
CREB Instruction of Macrophage Fate and Lung fluid homeostasis
CREB对巨噬细胞命运和肺液稳态的指导
- 批准号:
10305990 - 财政年份:2021
- 资助金额:
$ 39.13万 - 项目类别:
Nuclear Heparan Sulfate Mediates Fibroblast Activation in Indiopathic Pulmonary Fibrosis
核硫酸乙酰肝素介导特发性肺纤维化中成纤维细胞活化
- 批准号:
10199011 - 财政年份:2018
- 资助金额:
$ 39.13万 - 项目类别:
Regulation of Endothelial-Neutrophil Interaction and Lung Vascular Permeability in Sepsis
脓毒症中内皮-中性粒细胞相互作用和肺血管通透性的调节
- 批准号:
9788499 - 财政年份:2018
- 资助金额:
$ 39.13万 - 项目类别:
Regulation of Endothelial-Neutrophil Interaction and Lung Vascular Permeability in Sepsis
脓毒症中内皮-中性粒细胞相互作用和肺血管通透性的调节
- 批准号:
10004113 - 财政年份:2018
- 资助金额:
$ 39.13万 - 项目类别: